Abstract
ADRENOLEUKODYSTROPHY (ALD) is an X-linked disease affecting 1/20,000 males either as cerebral ALD in childhood or as adrenomyeloneuropathy (AMN) in adults1. Childhood ALD is the more severe form, with onset of neurological symptoms between 5–12 years of age. Central nervous system demyelination progresses rapidly and death occurs within a few years. AMN is a milder form of the disease with onset at 15–30 years of age and a more progressive course. Adrenal insufficiency (Addison's disease) may remain the only clinical manifestation of ALD. The principal biochemical abnormality of ALD is the accumulation of very-long-chain fatty acids (VLCFA) because of impaired β-oxidation in peroxisomes1,2. The normal oxidation of VLCFA-CoA in patients' fibroblasts3–5 suggested that the gene coding for the VLCFA-CoA synthetase could be a candidate gene for ALD. Here we use positional cloning to identify a gene partially deleted in 6 of 85 independent patients with ALD. In familial cases, the deletions segregated with the disease. An identical deletion was detected in two brothers presenting with different clinical ALD phenotypes. Candidate exons were identified by computer analysis of genomic sequences6 and used to isolate complementary DNAs by exon connection7 and screening of cDNA libraries. The deduced protein sequence shows significant sequence identity to a peroxisomal membrane protein of Mr 70K that is involved in peroxisome biogenesis and belongs to the ‘ATP-binding cassette’ superfamily of transporters.
Similar content being viewed by others
References
Moser, H. w. & Moser, A. in The Metabolic Basis of Inherited Disease (eds Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle. D.) 1511–1532 (McGraw-Hill, New York, 1989).
Singh, I., Moser, A. E., Goldfischer, S. & Moser, H. W. Proc. natn. Acad. Sci. U.S.A. 81, 4203–4207 (1984).
Hashmi, M., Stanley, W. & Singh, I. FEBS Lett. 196, 247–250 (1986).
Lazo, O. et al. Proc. natn. Acad. Sci. U.S.A. 85, 7647–7651 (1988).
Wanders, R. J. A. et al. J. inher. metab. Dis. 11, 173–177 (1988).
Uberbacher, E. C. & Mural, R. Proc. natn. Acad. Sci. U.S.A. 88, 11261–11265 (1992).
Fearon, E. R. et al. Science 247, 49–56 (1990).
Migeon, B. R. et al. Proc. natn. Acad. Sci. U.S.A. 78, 5066–5070 (1981).
Boué, J. et al. Hum. Genet 69, 272–274 (1985).
Aubourg, P., Sack, G. H., Meyers, D. A., Lease, J. J. & Moser, H. W. Ann. Neurol. 21, 349–352 (1987)
Nathans, J., Thomas, D. & Hogness, D. Science 232, 193–202 (1986).
Sack, G. H., Raven, B. & Moser, H. W. Am. J. hum. Genet. 44, 794–798 (1989).
Aubourg, P., Sack, G. H. & Moser, H. W. Am. J. hum. Genet. 42, 408–413 (1988).
Aubourg, P. et al. Am. J. hum. Genet. 46, 459–469 (1990).
Feil, R. et al. Am. J. hum. Genet. 49, 1361–1371 (1991).
Kioschis, P. et al. Cytogenet. Cell Genet. 58, 2070 (1991).
Kamijo, K., Taketani, S., Yokota, S., Osumi, T. & Hashimoto, T. J. biol. Chem. 265, 4534–4540 (1990).
Kamijo, K., Kamijo, T., Ueno, I., Osumi, T. & Hashimoto, T. Biochim. biophys. Acta 1129, 323–327 (1992).
Xiao, J. H. Davidson, I., Matthes, H., Garnier, J. M., & Chambon, P. Cell 65, 551–568 (1991).
Kozak, M. Nucleic Acids Res. 15, 8125–8148 (1987).
Gärtner, J., Moser, H. & Valle, D. Nature Genet. 1, 16–23 (1992).
Walker, J. E., Saraste, M., Runswick, M. J. & Gay, N. J. EMBO J 8, 945–951 (1982).
Suzuki, H. et al. J. biol. Chem. 265, 8681–8685 (1990).
Roninson, I. B. Molecular and Cellular Biology of Multidrug Resistance in Tumor cells (Plenum, New York, 1991).
Riordan, J. R. et al. Science 245, 1066–1080 (1989).
Trowsdale, J. et al. Nature 348, 741–744 (1990).
Bahram, S., Arnold, D., Bresnahan, M., Strominger, J. L. & Spies, T. Proc natn. Acad. Sci. U.S.A. 88, 10094–10098 (1991).
Cutting, G. R. et al. Nature 346, 366–369 (1990).
Higgins, C. F. et al. J. bioenerg. Biomembr. 22, 571–593 (1990).
Shimozawa, N. et al. Science 255, 1132–1134 (1992).
Erdmann, R. et al. Cell 64, 499–510 (1991).
Höhfeld, J., Veenhuis, M. & Kunau, W. H. J. cell Biol. 114, 1167–1178 (1992).
Imanaka, T., Small, G. M. & Lazarow, P. B. J. cell Biol. 105, 2915–2922 (1987).
Singh, I., Lazo, O., Dhaunsi, G. S. & Contreras, M. J. biol. Chem. 267, 13306–13313 (1992).
Sambrook, J., Fritsch, E. F. & Maniatis, T. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Press, New York, 1989).
Lipman, D. J. & Pearson, W. R. Science 227, 1435–1441 (1985).
Gilson, E., Nikaido, H. & Hofnung, M. Nucleic Acids Res. 10, 7449–7458 (1982).
Moser, H. W. et al. J. inher. metab. Dis. 15, 645–664 (1992).
Lazarow, P. B. & Moser, H. W. in The Metabolic Basis of Inherited Diseases (eds Scriver, C. R., Beaudet, A. L., Sly, W. S. & Valle, D.) 1479–1509 (McGraw-Hill, New York 1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mosser, J., Douar, AM., Sarde, CO. et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361, 726–730 (1993). https://doi.org/10.1038/361726a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/361726a0
- Springer Nature Limited
This article is cited by
-
Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma
BMC Urology (2024)
-
Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy
Acta Neuropathologica Communications (2023)
-
Hematopoietic stem-cell gene therapy is associated with restored white matter microvascular function in cerebral adrenoleukodystrophy
Nature Communications (2023)
-
Structural insights into substrate recognition and translocation of human peroxisomal ABC transporter ALDP
Signal Transduction and Targeted Therapy (2023)
-
Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy
Nature Communications (2021)